Site icon Asrar Qureshi’s Blogs

Corruption in Pharmaceuticals – International Perspective 8 – Blog Post #502 by Asrar Qureshi

Dear Colleagues!  This is Pharma Veterans Blog Post #502. Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi onWordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here.

Continued from Previous…… This series is based on a report compiled by Jilian Clare Cohen1, Monique Mrazek2, and Loraine Hawkins3 for World Bank.

Six decision points were identified where corruption could infiltrate. The first was manufacturing, second was marketing authorization, third was selection, fourth was procurement, fifth is discussed below.

Decision Point Five: Distribution

[Quote] Whether it is a government agency or a private company that is contracted out by the government to distribute drugs, the system needs to ensure the timely and safe delivery of appropriate quantities of drugs to health facilities and pharmacies where supplies are needed. Distribution and storage costs can comprise a significant amount of the retail price of a drug, especially when drugs are distributed to remote locations or where a lack of competition leads to inappropriate mark-ups by wholesalers and retailers.[Unquote]

Good Distribution Practice standardizes requirements for personnel, documentation, premises and equipment. Just one component of distribution such as poor storage conditions can lead to losses due to both the diversion (corruption) and expiration of drugs (inefficiency). A well-designed and well-managed distribution and storage system aims to:

There are several models for handling supply of drugs which are purchased for public consumption.

  1. Government procures all drugs centrally, stores these in a central store, which in Pakistan is called MSD (Medical Stores Depot). In this model, the government takes full responsibility for purchasing, storing, and distributing the drugs.

For many years, this model was used in Pakistan. Provincial governments purchased drugs and medical supplies through a bidding process and stored in the central store called MSD. All public health centers sent their demands before bidding which was added up for cumulative purchase. The centers were then supplied according to their demand. In this model, the prices remained uniform and the mandatory service charges related to government purchases remained within a reasonably small limit. Quality also remained constant, because high-quality and low-quality drugs were equally distributed across the province. Not everything was perfect in this system, but it worked fairly well.

This model was adopted after the centralized model in Pakistan. District Authorities were given budgets and were allowed to do purchases on their own. This led to huge variations in the type of drugs purchased, purchase prices, opened new avenues for corruption, and multiplied the service charges by a factor of five or more. The purchases suffered from other issues.

This system currently prevails in Punjab and Khyber Pakhtunkhwa (albeit a little variation). Provincial health directorate issues and finalizes tenders centrally; the districts place orders and receive supplies individually and directly. In addition, every teaching hospital is allowed to do their own bidding independently as these are not controlled by the provincial health directorate.

This model is not used in Pakistan. In fact, it was never used here.

This system is neither in vogue, nor ever used in Pakistan.

It cannot be said with certainty as to which system is better able to reduce the likelihood of corruption. What is needed for each of these models are oversight mechanisms, benchmark standards, and transparent procedures.

Good distribution is integral to making healthcare available at district/ tehsil/ rural level. [Quote] Strategies to reduce the risk of corruption include the following.

To be Continued……

Disclaimer. Most pictures in these blogs are taken from Google Images which does not show anyone’s copyright claim. However, if any such claim is presented, we shall remove the image with suitable regrets.

  1. Jilian Clare Cohen – Toronto, Canada
  2. Monique Mrazek – Latin America
  3. Loraine Hawkins – London

https://www.academia.edu/20118108/CORRUPTION_AND_PHARMACEUTICALS_STRENGTHENING_GOOD_GOVERNANCE_TO_IMPROVE_ACCESS?email_work_card=view-paper

Exit mobile version